0001580149 424B5 0001580149 2026-11-03 2026-11-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

Calculation of Filing Fee Tables

S-3

BIOVIE INC.

 

EX-FILING FEES 

Table 1: Newly Registered and Carry Forward Securities ☑Not Applicable

 

    Security
Type		 Security
Class
Title 		Fee
Calculation
or Carry Forward
Rule		 Amount
Registered		 Proposed
Maximum
Offering
Price
Per Unit		 Maximum
Aggregate
Offering
Price		 Fee Rate Amount of
Registration
Fee		 Carry Forward
Form Type		 Carry Forward
File
Number		 Carry Forward
Initial
Effective Date		 Filing Fee
Previously
Paid in
Connection
with Unsold
Securities
to be Carried
Forward
Newly Registered Securities
Fees to be Paid                          
Fees Previously Paid                          
Carry Forward Securities
Carry Forward Securities                          
      Total Offering Amounts:   $ 0.00   $ 0.00        
      Total Fees Previously Paid:       $ 0.00        
      Total Fee Offsets:       $ 0.00        
      Net Fee Due:       $ 0.00        

 

   

 

 

Table 2: Fee Offset Claims and Sources ☑Not Applicable

 

    Registrant
or Filer
Name 		Form or
Filing
Type 		File
Number 		Initial
Filing
Date 		Filing
Date 		Fee
Offset
Claimed 		Security
Type
Associated
with Fee
Offset
Claimed		 Security
Title
Associated
with Fee
Offset
Claimed 		Unsold
Securities
Associated
with Fee
Offset
Claimed 		Unsold
Aggregate
Offering
Amount
Associated
with Fee
Offset
Claimed 		Fee
Paid
with
Fee
Offset
Source
Rules 457(b) and 0-11(a)(2)
Fee Offset Claims                        
Fee Offset Sources                        
Rule 457(p)
Fee Offset Claims                        
Fee Offset Sources                        

 

Table 3: Combined Prospectuses ☑Not Applicable

 

  Security
Type		 Security
Class Title		 Amount of Securities
Previously Registered		 Maximum Aggregate Offering
Price of Securities Previously
Registered		 Form
Type		 File
Number		 Initial
Effective
Date
               
Narrative Disclosure

 

The maximum aggregate offering price of the securities to which the prospectus relates is $4,740,000.00. The prospectus is a final prospectus for the related offering.

 

The prospectus supplement to which this exhibit is attached is a final prospectus for the related offering and relates to the Registration Statement on Form S-3 (No. 333-296924) filed by BioVie Inc. on June 18, 2026 and declared effective on June 29, 2026.